Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Med (New York, N.Y.)|January 11, 2025
Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancerShimon SlavinActa Haematologica|November 5, 2005
Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantationShimon SlavinJournal of Cancer Research and Clinical Oncology|May 18, 2023
Immunotherapy with cure potential of multi-drug resistant hematologic malignancies using IL-2 preactivated intentionally mismatched donor lymphocyteShimon SlavinInternational Journal of Hematology|November 15, 2002
Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantationShimon SlavinInternational Journal of Hematology|November 8, 2003
Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantationShimon SlavinExpert Review of Hematology|November 19, 2010
Immunoregulation of GVHD by triggering the innate immune system with CpGShoshana Morecki, Shimon SlavinSpringer Seminars in Immunopathology|September 16, 2004
Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allograftsTatyana Prigozhina, Shimon SlavinJournal of the Neurological Sciences|July 21, 2004
Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the proceduresDimitrios Karussis, Shimon SlavinMedical Hypotheses|June 27, 2006
The hematological etiology of osteoporosisOlga Gurevitch, Shimon SlavinStem Cells and Development|March 31, 2009
A method for isolating pluripotent/multipotent stem cells from blood by using the pluripotent and germ-line DAZL gene as a markerJudith Seligman, Shimon Slavin, Ina FabianPageof 14